Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Impact of Daratumumab-Based Regimens on Survival and Minimal Residual Disease Negativity in Multiple Myeloma: A Systematic Review and Meta-Analysis

MM - 1537

Impact of Daratumumab-Based Regimens on Survival and Minimal Residual Disease Negativity in Multiple Myeloma: A Systematic Review and Meta-Analysis

Anubhuti Sharma

Poster Presenter: Anubhuti Sharma

Thumbnail for Impact of Pre-Existing Anxiety and Depression on Toxicity and Outcomes After Axicabtagene Ciloleucel for Patients With Diffuse Large B-Cell Lymphoma

CT - 1538

Impact of Pre-Existing Anxiety and Depression on Toxicity and Outcomes After Axicabtagene Ciloleucel for Patients With Diffuse Large B-Cell Lymphoma

Laith Hamed

Poster Presenter: Laith Hamed

Previous 1...123 124 125 126 127 128 129...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Sociodemographic Factors and Treatment Patterns Associated With Overall Survival in Splenic Marginal Zone Lymphoma: A Nationwide Retrospective Cohort Study (2000-2022)

IBCL - 1540

Sociodemographic Factors and Treatment Patterns Associated With Overall Survival in Splenic Marginal Zone Lymphoma: A Nationwide Retrospective Cohort Study (2000-2022)

Manas Pustake

Poster Presenter: Manas Pustake

Thumbnail for Impact of Pre-Existing Cognitive Impairments on Toxicity and Outcomes After Axicabtagene Ciloleucel for Patients With Diffuse Large B-Cell Lymphoma

CT - 1541

Impact of Pre-Existing Cognitive Impairments on Toxicity and Outcomes After Axicabtagene Ciloleucel for Patients With Diffuse Large B-Cell Lymphoma

Laith Hamed

Poster Presenter: Laith Hamed

$Thumbnail for Cardiovascular Adverse Event Reporting Patterns With BCMA-Directed CAR-T and BCMA/GPRC5D Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A FAERS Disproportionality Analysis$

MM - 1542

Cardiovascular Adverse Event Reporting Patterns With BCMA-Directed CAR-T and BCMA/GPRC5D Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A FAERS Disproportionality Analysis

B?sranur Yilmaz

Poster Presenter: B?sranur Yilmaz

$Thumbnail for Predicting Tolerance and Responses to BTKi in CLL Patients with Treatment-Naοve or Relapsed/Refractory Disease Using Pharmacogenomics$

CLL - 1544

Predicting Tolerance and Responses to BTKi in CLL Patients with Treatment-Naοve or Relapsed/Refractory Disease Using Pharmacogenomics

Fahmin Basher

Poster Presenter: Fahmin Basher

Thumbnail for Quizartinib Combined with Cladribine, Idarubicin, and Cytarabine (CLIA) in AML

AML - 1545

Quizartinib Combined with Cladribine, Idarubicin, and Cytarabine (CLIA) in AML

Musa Yilmaz

Poster Presenter: Musa Yilmaz

Thumbnail for Survival Trends and Prevalence Disparities in Large Granular Lymphocytic Leukemia: A Multivariate Population Based Retrospective Study.

CLL - 1546

Survival Trends and Prevalence Disparities in Large Granular Lymphocytic Leukemia: A Multivariate Population Based Retrospective Study.

Hassan Ali

Poster Presenter: Hassan Ali

$Thumbnail for Efficacy and Safety Outcomes of Teclistamab in Relapsed/Refractory Multiple Myeloma: A Systematic Review$

MM - 1547

Efficacy and Safety Outcomes of Teclistamab in Relapsed/Refractory Multiple Myeloma: A Systematic Review

Maha Hameed

Poster Presenter: Maha Hameed

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors